SQZ Biotechnologies Company

SQZ Biotechnologies Company

SQZB - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$707.79K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
SQZ Biotechnologies CompanySQZ Biotechnologies Company0--181%-11.4

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$707,787.00
Enterprise Value$11.99 Million
Earnings per Share$-2.76
Beta0.32
Outstanding Shares29,491,125

Return

Return on Equity-180.60%ROE
Return on Assets-11.40%
Return on Invested Capital-349.27%

Valuation & Multiples

P/E Ratio-0.01P/E Ratio
PEG0.01PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.98
Enterprise Value to EBIT-0.16
Enterprise Value to Net Income-4
Total Debt to Enterprise1.79
Debt to Equity11.42Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 12, 2026
EPS Estimate
-$0.58
Consensus analyst estimate
Revenue Estimate
$4.66 M
Consensus analyst estimate

Next Earnings Call

Expected Date
March 25, 2027
EPS Estimate
-$0.57
Consensus analyst estimate
Revenue Estimate
$5.79 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About SQZ Biotechnologies Co

98 employees
CEO: Howard Bernstein

SQZ Biotechnologies is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ Biotechnologies off...